458
Views
28
CrossRef citations to date
0
Altmetric
Original Research

Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement

, , , , , , , , , & show all
Pages 443-457 | Received 21 Dec 2017, Accepted 07 Mar 2018, Published online: 13 Mar 2018

References

  • Tulbah AS, Ong HX, Morgan L, et al. Dry powder formulation of simvastatin. Expert Opin Drug Deliv. 2015 Jun;12(6):857–868. PubMed PMID: 25244365.
  • Salama RO, Young PM, Traini D. Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline. Drug Deliv Transl Rev. 2014 Jun;4(3):256–267. PubMed PMID: WOS:000357370400006; English.
  • Patil HP, Murugappan S, Ter Veer W, et al. Evaluation of monophosphoryl lipid A as adjuvant for pulmonary delivered influenza vaccine. J Control Release. 2014 Jan 28;174:51–62. PubMed PMID: WOS:000329964500007; English.
  • de Boer AH, Hagedoorn P, Hoppentocht M, et al. Dry powder inhalation: past, present and future. Expert Opin Drug Deliv. 2017 Apr;14(4):499–512. PubMed PMID: WOS:000396033900007; English.
  • Ruigrok MJR, Frijlink HW, Hinrichs WLJ. Pulmonary administration of small interfering RNA: the route to go? J Control Release. 2016 Aug 10;235:14–23.
  • Frohlich E. Toxicity of orally inhaled drug formulations at the alveolar barrier: parameters for initial biological screening. Drug Delivery. 2017 Nov;24(1):891–905. PubMed PMID: 28574335.
  • Mwesigwa E, Basit AW. An investigation into moisture barrier film coating efficacy and its relevance to drug stability in solid dosage forms. Int J Pharm. 2016 Jan 30;497(1–2):70–77. PubMed PMID: WOS:000367385600010; English.
  • Muhsin MDA, George G, Beagley K, et al. Effects of chemical conjugation of L-Leucine to chitosan on dispersibility and controlled release of drug from a nanoparticulate dry powder inhaler formulation. Mol Pharm. 2016 May;13(5):1455–1466. PubMed PMID: WOS:000375519600003; English.
  • Pilcer G, Amighi K. Formulation strategy and use of excipients in pulmonary drug delivery. Int J Pharm. 2010 Jun 15;392(1–2):1–19. PubMed PMID: WOS:000278346500001; English.
  • Kaialy W, Nokhodchi A. Dry powder inhalers: physicochemical and aerosolization properties of several size-fractions of a promising alterative carrier, freeze-dried mannitol. Eur J Pharm Sci. 2015 Feb 20;68:56–67.
  • Mahajan HS, Gundare SA. Preparation, characterization and pulmonary pharmacokinetics of xyloglucan microspheres as dry powder inhalation. Carbohydr Polym. 2014 Feb 15;102:529–536.
  • Li L, Sun SP, Parumasivam T, et al. l-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Eur J Pharm Biopharm. 2016 May;102:132–141. PubMed PMID: WOS:000374622300015; English.
  • Rahimpour Y, Kouhsoltani M, Hamishehkar H. Alternative carriers in dry powder inhaler formulations. Drug Discov Today. 2014 May;19(5):618–626. PubMed PMID: WOS:000336949400010; English.
  • Watts AB, Wang YB, Johnston KP, et al. Respirable low-density microparticles formed in situ from aerosolized brittle matrices. Pharm Res. 2013 Mar;30(3):813–825. PubMed PMID: WOS:000315294800017; English.
  • Maeda H, Iga Y, Nakayama H. Characterization of inclusion complexes of betahistine with beta-cyclodextrin and evaluation of their anti-humidity properties. J Incl Phenom Macro. 2016 Dec;86(3–4):337–342. PubMed PMID: WOS:000387445400017; English.
  • de Miranda JC, Martins TEA, Veiga F, et al. Cyclodextrins and ternary complexes: technology to improve solubility of poorly soluble drugs. Braz J Pharm Sci. 2011 Oct–Dec;47(4):665–681. PubMed PMID: WOS:000302521000003; English.
  • Tonglairoum P, Ngawhirunpat T, Rojanarata T, et al. Fabrication and evaluation of nanostructured herbal oil/hydroxypropyl-beta-cyclodextrin/polyvinylpyrrolidone mats for denture stomatitis prevention and treatment. AAPS PharmSciTech. 2016 Dec;17(6):1441–1449. PubMed PMID: WOS:000392104000017; English.
  • Mohtar N, Taylor KMG, Sheikh K, et al. Design and development of dry powder sulfobutylether-beta-cyclodextrin complex for pulmonary delivery of fisetin. Eur J Pharm Biopharm. 2017 Apr;113:1–10. PubMed PMID: WOS:000396953400001; English.
  • Vartiainen V, Bimbo LM, Hirvonen J, et al. Aerosolization, drug permeation and cellular interaction of dry powder pulmonary formulations of corticosteroids with hydroxypropyl-beta-cyclodextrin as a solubilizer. Pharm Res. 2017 Jan;34(1):25–35. PubMed PMID: WOS:000391431900003; English.
  • Jyoti K, Pandey RS, Kush P, et al. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells. Int J Biol Macromol. 2017 May;98:50–58. PubMed PMID: WOS:000396950600006; English.
  • Devrim B, Bozkir A, Canefe K. Preparation and evaluation of poly(lactic-co-glycolic acid) microparticles as a carrier for pulmonary delivery of recombinant human interleukin-2: II. In vitro studies on aerodynamic properties of dry powder inhaler formulations. Drug Dev Ind Pharm. 2011 Nov;37(11):1376–1386. PubMed PMID: WOS:000295693300014; English.
  • Kurniawansyah F, Mammucari R, Foster NR. Inhalable curcumin formulations by supercritical technology. Powder Technol. 2015 Nov;284:289–298. PubMed PMID: WOS:000361582300034; English.
  • van den Hoven JM, Metselaar JM, Storm G, et al. Cyclodextrin as membrane protectant in spray-drying and freeze-drying of PEGylated liposomes. Int J Pharm. 2012 Nov 15;438(1–2):209–216. PubMed PMID: WOS:000310763700024; English.
  • Peng TT, Zhang XJ, Huang Y, et al. Nanoporous mannitol carrier prepared by non-organic solvent spray drying technique to enhance the aerosolization performance for dry powder inhalation. Sci Rep UK. 2017 May 2;7. ARTN 46517 PubMed PMID: WOS:000400452100001; English.. DOI:10.1038/srep46517.
  • Sarrate R, Tico JR, Minarro M, et al. Modification of the morphology and particle size of pharmaceutical excipients by spray drying technique. Powder Technol. 2015 Jan;270:244–255. PubMed PMID: WOS:000347579300027; English.
  • Healy AM, McDonald BF, Tajber L, et al. Characterisation of excipient-free nanoporous microparticles (NPMPs) of bendroflumethiazide. Eur J Pharm Biopharm. 2008 Aug;69(3):1182–1186. PubMed PMID: 18595674.
  • Lu XY, Chen L, Wu CY, et al. The effects of relative humidity on the flowability and dispersion performance of lactose mixtures. Materials. 2017 Jun;10(6). ARTN 592 PubMed PMID: WOS:000404415000026; English. DOI:10.3390/ma10060592
  • Gnagne EH, Petit J, Gaiani C, et al. Characterisation of flow properties of foutou and foufou flours, staple foods in West Africa, using the FT4 powder rheometer. J Food Meas Charact. 2017 Sep;11(3):1128–1136. PubMed PMID: WOS:000406023300022; English.
  • Amaro MI, Tajber L, Corrigan OI, et al. Co-spray dried carbohydrate microparticles: crystallisation delay/inhibition and improved aerosolization characteristics through the incorporation of hydroxypropyl-beta-cyclodextrin with amorphous raffinose or trehalose. Pharm Res. 2015 Jan;32(1):180–195. PubMed PMID: WOS:000347408800013; English.
  • Case DA, Cheatham TE, Darden T, et al. The Amber biomolecular simulation programs. J Comput Chem. 2005 Dec;26(16):1668–1688. PubMed PMID: WOS:000233021400002; English.
  • Bush IJ, Todorov IT, Smith W. A DAFT DL_POLY1 distributed memory adaptation of the smoothed particle mesh Ewald method. Comput Phys Commun. 2006 Sep 1;175(5):323–329. PubMed PMID: WOS:000240301300002; English.
  • Forester TR, Smith W. SHAKE, rattle, and roll: efficient constraint algorithms for linked rigid bodies (vol 19, pg 102, 1998). J Comput Chem. 2000 Jan 30;21(2):157.
  • Du P, Du J, Smyth HDC. Evaluation of granulated lactose as a carrier for dry powder inhaler formulations 2: effect of drugs and drug loading. J Pharm Sci. 2017 Jan;106(1):366–376. PubMed PMID: WOS:000393920500040; English.
  • Quan GL, Pan X, Wang ZH, et al. Lactosaminated mesoporous silica nanoparticles for asialoglycoprotein receptor targeted anticancer drug delivery. J Nanobiotechnol. 2015 Feb 3;13. ARTN 7 PubMed PMID: WOS:000351129200002; English. DOI:10.1186/s12951-015-0068-6.
  • Duret C, Wauthoz N, Merlos R, et al. In vitro and in vivo evaluation of a dry powder endotracheal insufflator device for use in dose-dependent preclinical studies in mice. Eur J Pharm Biopharm. 2012 Aug;81(3):627–634. PubMed PMID: WOS:000307040900020; English.
  • Zhang X, Liu Q, Hu J, et al. An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation. Acta Pharm Sin B. 2014 Feb;4(1):79–85. PubMed PMID: 26579368; PubMed Central PMCID: PMCPMC4590724.
  • Ludwig B, Miller TF. Rheological and surface chemical characterization of alkoxysilane treated, fine aluminum powders showing enhanced flowability and fluidization behavior for delivery applications. Powder Technol. 2015 Oct;283:380–388. PubMed PMID: WOS:000361263300041; English.
  • Cordts E, Steckel H. Capabilities and limitations of using powder rheology and permeability to predict dry powder inhaler performance. Eur J Pharm Biopharm. 2012 Oct;82(2):417–423. PubMed PMID: WOS:000312043300022; English.
  • Hertel M, Schwarz E, Kobler M, et al. Powder flow analysis: a simple method to indicate the ideal amount of lactose fines in dry powder inhaler formulations. Int J Pharm. 2018 1 15;535(1–2):59–67.
  • Teekamp N, Tian Y, Visser JC, et al. Addition of pullulan to trehalose glasses improves the stability of beta-galactosidase at high moisture conditions. Carbohydr Polym. 2017 Nov 15;176:374–380. PubMed PMID: WOS:000410970900043; English.
  • Giuffrida S, Cottone G, Vitrano E, et al. A FTIR study on low hydration saccharide amorphous matrices: thermal behaviour of the water association band. J Non-Cryst Solids. 2011 Jan 15;357(2):677–682. PubMed PMID: WOS:000287640800075; English.
  • Xu W, Yu SH, Liu Q, et al. Enzymatic production of melibiose from raffinose by the levansucrase from leuconostoc mesenteroides B-512 FMC. J Agric Food Chem. 2017 May 17;65(19):3910–3918. PubMed PMID: WOS:000401782300015; English.
  • Kota P, Ding F, Ramachandran S, et al. Gaia: automated quality assessment of protein structure models. Bioinformatics. 2011 Aug 15;27(16):2209–2215. PubMed PMID: WOS:000293620800006; English.
  • Arsalan N, Palayangoda SS, Burnett DJ, et al. Surface energy characterization of carbonate rocks. Colloid Surf A. 2013 Sep 5;436:139–147. PubMed PMID: WOS:000326416900019; English.
  • Blasi P, D’Souza SS, Selmin F, et al. Plasticizing effect of water on poly(lactide-co-glycolide). J Control Release. 2005 Nov 2;108(1):1–9. PubMed PMID: WOS:000233321200001; English.
  • Abadelah M, Hazim F, Chrystyn H, et al. Effect of maximum inhalation flow and inhaled volume on formoterol drug deposition in-vitro from an Easyhaler (R) dry powder inhaler. Eur J Pharm Sci. 2017 Jun 15;104:180–187. PubMed PMID: WOS:000405251600019; English.
  • Buttini F, Soltani A, Colombo P, et al. Multilayer PVA adsorption onto hydrophobic drug substrates to engineer drug-rich microparticles. Eur J Pharm Sci. 2008 Jan;33(1):20–28. PubMed PMID: WOS:000252654300003; English.
  • Littringer EM, Mescher A, Schroettner H, et al. Spray dried mannitol carrier particles with tailored surface properties – the influence of carrier surface roughness and shape. Eur J Pharm Biopharm. 2012 Sep;82(1):194–204. PubMed PMID: WOS:000309627200023; English.
  • Karner S, Littringer EM, Urbanetz NA. Triboelectrics: the influence of particle surface roughness and shape on charge acquisition during aerosolization and the DPI performance. Powder Technol. 2014 Aug;262:22–29. PubMed PMID: WOS:000338610500004; English.
  • Kumon M, Suzuki M, Kusai A, et al. Novel approach to DPI carrier lactose with mechanofusion process with additives and evaluation by IGC. Chem Pharm Bull. 2006 Nov;54(11):1508–1514. PubMed PMID: WOS:000242481000005; English.
  • Crini G. Review: a history of cyclodextrins. Chem Rev. 2014 Nov 12;114(21):10940–10975. PubMed PMID: WOS:000344906200006; English.
  • Loftsson T, Jarho P, Masson M, et al. Cyclodextrins in drug delivery. Expert Opin Drug Deliv. 2005 Mar;2(2):335–351. PubMed PMID: 16296758.
  • Messner M, Kurkov SV, Jansook P, et al. Self-assembled cyclodextrin aggregates and nanoparticles. Int J Pharm. 2010 Mar 15;387(1–2):199–208. PubMed PMID: WOS:000275436800027; English.
  • Hetrick EM, Kramer TT, Risley DS. Evaluation of a hydrophilic interaction liquid chromatography design space for sugars and sugar alcohols. J Chromatogr A. 2017 Mar 17;1489:65–74.
  • Meng XH, Pan QY, Liu Y. Preparation and properties of phytosterols with hydroxypropyl beta-cyclodextrin inclusion complexes. Eur Food Res Technol. 2012 Dec;235(6):1039–1047. PubMed PMID: WOS:000311392100006; English.
  • Messner M, Kurkov SV, Palazon MM, et al. Self-assembly of cyclodextrin complexes: effect of temperature, agitation and media composition on aggregation. Int J Pharm. 2011 Oct 31;419(1–2):322–328. PubMed PMID: WOS:000296307000042; English.
  • Kim EHJ, Chen XD, Pearce D. Surface characterization of four industrial spray-dried dairy powders in relation to chemical composition, structure and wetting property. Colloid Surf B. 2002 Oct;26(3):197–212. Pii S0927-7765(02)00334-4. PubMed PMID: WOS:000178903300002; English.
  • Liu WJ, Wu WD, Selomulya C, et al. Facile spray-drying assembly of uniform microencapsulates with tunable core-shell structures and controlled release properties. Langmuir. 2011 Nov 1;27(21):12910–12915. PubMed PMID: WOS:000296211800019; English.
  • Chen XD, Sidhu H, Nelson M. Theoretical probing of the phenomenon of the formation of the outermost surface layer of a multi-component particle, and the surface chemical composition after the rapid removal of water in spray drying. Chem Eng Sci. 2011 Dec 15;66(24):6375–6384. PubMed PMID: WOS:000296568500010; English.
  • Kim EHJ, Chen XD, Pearce D. Surface composition of industrial spray-dried milk powders. 2. Effects of spray drying conditions on the surface composition. J Food Eng. 2009 Sep;94(2):169–181. PubMed PMID: WOS:000267236900007; English.
  • Kurkov SV, Loftsson T. Cyclodextrins. Int J Pharm. 2013 Aug 30;453(1):167–180. PubMed PMID: WOS:000321741100015; English.
  • Malamatari M, Somavarapu S, Taylor KMG, et al. Solidification of nanosuspensions for the production of solid oral dosage forms and inhalable dry powders. Expert Opin Drug Deliv. 2016 Mar 3;13(3):435–450. PubMed PMID: WOS:000370434200002; English.
  • Stappaerts J, Thi TD, Dominguez-Vega E, et al. The impact of guest compounds on cyclodextrin aggregation behavior: a series of structurally related parabens. Int J Pharm. 2017 Aug 30;529(1–2):442–450. PubMed PMID: WOS:000408009200041; English.
  • Tong HHY, Wong SYS, Law MWL, et al. Anti-hygroscopic effect of dextrans in herbal formulations. Int J Pharm. 2008 Nov 3;363(1–2):99–105. PubMed PMID: WOS:000260478700011; English.
  • Suihko E, Korhonen O, Järvinen T, et al. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-β-cyclodextrin. Int J Pharm. 2001 03 14;215(1):137–145.
  • Chvatal A, Farkas A, Balashazy I, et al. Aerodynamic properties and in silico deposition of meloxicam potassium incorporated in a carrier-free DPI pulmonary system. Int J Pharm. 2017 Mar 30;520(1–2):70–78. PubMed PMID: WOS:000396948400008; English.
  • Chan HK. What is the role of particle morphology in pharmaceutical powder aerosols? Expert Opin Drug Deliv. 2008 Aug 5;(8):909–914. PubMed PMID: WOS:000259741500007; English. Doi:10.1517/17425247.5.8.909
  • Nguyen VH, Deleglise-Lagardere M, Park CH. Modeling of resin flow in natural fiber reinforcement for liquid composite molding processes. Compos Sci Technol. 2015 Jun 5;113:38–45.
  • Mangal S, Gengenbach T, Millington-Smith D, et al. Relationship between the cohesion of guest particles on the flow behaviour of interactive mixtures. Eur J Pharm Biopharm. 2016 May;102:168–177. PubMed PMID: WOS:000374622300019; English.
  • Shalash AO, Khalafallah NM, Molokhia AM, et al. The relationship between the permeability and the performance of carrier-based dry powder inhalation mixtures: new insights and practical guidance. AAPS PharmSciTech. 2017 October 23. DOI:10.1208/s12249-017-0898-7.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.